Skip survey header

9087 ATS Enduring Evaluation

IPF Disease Challenge

DEMOGRAPHICS
6. BEFORE taking this educational activity, how would you have rated your ability to: *This question is required.
Space Cell 0 - Not Relevant1 - Low2345 - High
Integrate new information on IPF treatment into practice as it becomes available in your practice?
Confidence in discussing timing and rationale for starting antifibrotic therapy in your practice?
Rate your confidence to decide when to stop or switch treatment in your practice?
Identify and manage comorbidities associated with IPF in your practice?
7. AFTER taking this educational activity, how would you have rated your ability to: *This question is required.
Space Cell 0 - Not Relevant1 - Low2345 - High
Integrate new information on IPF treatment into practice as it becomes available in your practice?
Confidence in discussing timing and rationale for starting antifibrotic therapy in your practice?
Rate your confidence to decide when to stop or switch treatment in your practice?
Identify and manage comorbidities associated with IPF in your practice?
PRACTICAL APPLICATION
*If yes or possibly considering changes, please check off what you intend to do differently or incorporate into your clinical management of patients as a result of this educational activity. *This question is required.
SATISFACTION